Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Response Effects of Intravenous Ketamine Infusions for Refractory Chronic Non-Cancer Pain
TCTR20260324006Phase 3Not yet recruiting
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in Chronic non-cancer pain (CNCP), sponsored by none. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
Chronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on TCTR20260324006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260324006.